Steven Cohen’s Roivant Sciences ROIV Stock Holding History

Steven Cohen’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$158M	Buy	4,473,478 +3,582,578	+402%	+$106M	0.17%	111
2026 Q1	$24.7M	Buy	+890,900	New	+$22.9M	0.03%	699
2025 Q4	–	Sell	-2,608,294	Closed	-$51.5M	–	4128
2025 Q3	$39.5M	Sell	2,608,294 -342,838	-12%	-$4.24M	0.07%	316
2025 Q2	$33.3M	Buy	2,951,132 +2,336,817	+380%	+$25.3M	0.07%	339
2025 Q1	$6.2M	Buy	+614,315	New	+$6.64M	0.01%	848
2024 Q3	–	Sell	-647,126	Closed	-$6.84M	–	2290
2024 Q2	$6.84M	Buy	647,126 +185,226	+40%	+$2.03M	0.02%	752
2024 Q1	$4.87M	Buy	461,900 +28,200	+7%	+$304K	0.01%	972
2023 Q4	$4.87M	Sell	433,700 -2,272,700	-84%	-$22.1M	0.01%	933
2023 Q3	$31.6M	Buy	+2,706,400	New	+$30.6M	0.09%	283
2023 Q1	–	Sell	-576,800	Closed	-$4.61M	–	2507
2022 Q4	$4.61M	Buy	+576,800	New	+$3.21M	0.02%	776
2022 Q3	–	Sell	-876,996	Closed	-$3.57M	–	1686
2022 Q2	$3.57M	Buy	+876,996	New	+$3.48M	0.02%	793

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Steven Cohen's ROIV Position: Q2 2026 in Review

Steven Cohen increased its Roivant Sciences (ROIV) stake by 402% in Q2 2026, buying an estimated $106M and bringing the position to 4,473,478 shares worth $158M. The position accounts for 0.17% of the portfolio, ranked #111.

Steven Cohen first reported a position in ROIV in Q2 2022 and has held it in 11 quarters since. 495 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Steven Cohen held 4,473,478 shares of Roivant Sciences worth $158M as of Q2 2026.
Steven Cohen bought 3,582,578 Roivant Sciences shares in Q2 2026, an estimated $106M.
Roivant Sciences made up 0.17% of Steven Cohen's portfolio in Q2 2026, its #111 holding.
Steven Cohen first reported a position in Roivant Sciences in Q2 2022 and has held it in 11 quarters since.
495 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.